PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma

J Invest Dermatol. 2020 Nov;140(11):2301-2304.e3. doi: 10.1016/j.jid.2020.03.948. Epub 2020 Apr 8.

Authors

Felix F Kung¹, Suzette M Arias-Mejias², Enrica Quattrocchi², Sindhuja Sominidi-Damodaran², Alina G Bridges³, Julia S Lehman³, Amy L Weaver⁴, Alexander Meves⁵

Affiliations

¹ Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
³ Division of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
⁵ Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: meves.alexander@mayo.edu.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
B7-H1 Antigen / analysis
B7-H1 Antigen / genetics*
Bcl-2-Like Protein 11 / analysis
Bcl-2-Like Protein 11 / genetics*
Female
Humans
Integrin beta3 / analysis
Integrin beta3 / genetics
Lymphatic Metastasis
Male
Melanoma / metabolism
Melanoma / pathology*
Middle Aged
Programmed Cell Death 1 Receptor / analysis
Programmed Cell Death 1 Receptor / genetics*
Sentinel Lymph Node / pathology*
Skin Neoplasms / metabolism
Skin Neoplasms / pathology*
Young Adult

Substances

B7-H1 Antigen
Bcl-2-Like Protein 11
CD274 protein, human
Integrin beta3
PDCD1 protein, human
Programmed Cell Death 1 Receptor

Grants and funding